Opinion

Video

Optimizing Bispecific Antibody Use: Opportunities to Broaden Patient Access

Experts discuss which patient populations stand to benefit the most from recently approved bispecific therapies, identifying gaps or opportunities for further patient benefit, as well as the data gaps that exist in understanding the optimal use of bispecific antibodies across various cancer types.

Video content above is prompted by the following:

  • What patient populations stand to benefit the most from recently approved bispecific therapies?
  • Where are gaps or opportunities for patient populations to further benefit from bispecifics?
  • What data gaps exist in understanding the optimal use of bispecific antibodies across various cancer types?
Related Videos
5 experts are featured in this series
5 experts are featured in this series
Christine Funke, MD
1 expert in this video
1 expert in this video
Dr Mingyang Song
Casey Koch, PharmD, sitting for a video interview
1 expert in this video
1 expert in this video
Dr John Heymach
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo